scholarly journals Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR ‐tyrosine kinase inhibitors

2021 ◽  
Author(s):  
Sheng‐Yuan Wang ◽  
Ching‐Han Lai ◽  
Chian‐Wei Chen ◽  
Szu‐Chun Yang ◽  
Chao‐Chun Chang ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Stage Iii ◽  
Egfr Tyrosine Kinase ◽  
Unresectable Stage ◽  
Egfr Tyrosine Kinase Inhibitors ◽  
Egfr Mutant

scholarly journals Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or Gefitinib

2011 ◽  
Vol 17 (19) ◽  
pp. 6322-6328 ◽  
Author(s):  
Geoffrey R. Oxnard ◽  
Yelena Y. Janjigian ◽  
Maria E. Arcila ◽  
Camelia S. Sima ◽  
Samantha L. Kass ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Egfr Tyrosine Kinase ◽  
Egfr Tyrosine Kinase Inhibitors ◽  
Egfr Mutant
Sign in / Sign up

Export Citation Format

Share Document